Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

16 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/16/3206511/0/en/Orchard-Therapeutics-Celebrates-Addition-of-Metachromatic-Leukodystrophy-to-the-U-S-Recommended-Uniform-Screening-Panel.html

28 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/28/3175097/0/en/Kyowa-Kirin-and-Orchard-Therapeutics-Announce-OTL-200-Granted-Orphan-Regenerative-Medicine-Product-Designation-for-Early-onset-MLD-in-Japan.html

07 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/07/3110914/0/en/Orchard-Therapeutics-Announces-Last-Patient-Treated-in-Registrational-Trial-of-OTL-203-for-MPS-I-Hurler-Syndrome.html

13 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/13/3079960/0/en/Orchard-Therapeutics-Announces-New-England-Journal-of-Medicine-Publication-of-Long-term-Clinical-Outcomes-from-its-HSC-Gene-Therapy-for-MLD-and-Multiple-Presentations-at-ASGCT-2025.html

28 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/28/3034520/0/en/Orchard-Therapeutics-Announces-Reimbursement-Agreement-in-Spain.html

12 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/12/3024917/0/en/Orchard-Therapeutics-Appoints-Robin-Kenselaar-to-Chief-Commercial-Officer-and-Announces-Multiple-Business-Updates-Pertaining-to-its-Approved-HSC-Gene-Therapy-for-MLD.html
ABOUT THIS PAGE